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OBJECTIVES: Newborns who undergo surgery for gastroschisis correction may present with oliguria, anasarca,
prolonged postoperative ileus, and infection. New postoperative therapeutic procedures were tested with the
objective of improving postoperative outcome.
PATIENTS AND METHODS: One hundred thirty-six newborns participated in one of two phases. Newborns in the
first phase received infusions of large volumes of crystalloid solution and integral enteral formula, and newborns in
the second phase received crystalloid solutions in smaller volumes, with albumin solution infusion when necessary
and the late introduction of a semi-elemental diet. The studied variables were serum sodium and albumin levels, the
need for albumin solution expansion, the occurrence of anasarca, the length of time on parenteral nutrition, the
length of time before initiating an enteral diet and reaching a full enteral diet, orotracheal intubation time, length
of hospitalization, and survival rates.
RESULTS: Serum sodium levels were higher in newborns in the second phase. There was a correlation between low
serum sodium levels and orotracheal intubation time; additionally, low serum albumin levels correlated with the
length of time before the initiation of an oral diet and the time until a full enteral diet was reached. However, the
discharge weights of newborns in the second phase were higher than in the first phase. The other studied variables,
including survival rates (83.4% and 92.0%, respectively), were similar for both phases.
CONCLUSIONS: The administration of an albumin solution to newborns in the early postoperative period following
gastroschisis repair increased their low serum sodium levels but did not improve the final outcome. The introduction
of a semi-elemental diet promoted an increase in body weight at the time of discharge.
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INTRODUCTION
In recent decades, the worldwide incidence of gastro-
schisis has increased (1-3). Despite survival rates higher
than 90% (4,5), newborns (NBs) with gastroschisis demon-
strate significant postoperative morbidity associated with
long periods of hospitalization (6).
Surgical treatment for gastroschisis includes viscera
reduction inside the cavity and abdominal wall closure in
one- or two-stage procedures, always with at least a slight
intra-abdominal tension (7). Patients in the early post-
operative period tend to present with hydrosaline retention
and fluid losses into the traumatic edema zone. These
problems occur in association with increased intra-abdom-
inal pressure due to reduced peritoneal cavity capacity and
a consequent decrease in diuresis (8).
The classic treatment for NBs in the first two days after
gastroschisis correction includes the administration of large
volumes of hydration solutions and, if necessary, repeated
expansion of the extracellular compartment with crystalloid
solutions, which invariably leads to anasarca and diluted low
serum levels. These results have deleterious consequences,
specifically interstitial pulmonary edema and respiratory
dysfunction (9). In a previous investigation involving a large
number of patients with surgically repaired gastroschisis at
three tertiary university centers, we demonstrated that the
presence of hyponatremia and hypoalbuminemia in the
postoperative period correlated with the number of days that
the patient required a ventilator (10).
To avoid this vicious cycle, we proposed a different
treatment in the current study. Instead of administering
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large volumes of crystalloid solution, a basal maintenance
solution was administered in standard volumes, even if
diuresis rates were low. In cases with more intense oliguria,
albumin solution was administered in an attempt to
maintain the intravascular compartment volume.
Another problem frequently found in NBs who have
undergone gastroschisis repair is the prolonged postopera-
tive ileus (11,12). The introduction of an enteral diet can be
difficult because of repeated vomiting, abdominal disten-
tion, intestinal malabsorption of nutrients, and enterocolitis
episodes. Special diets may reduce the risk of these
complications (13), but this practice has not yet been proven
in the medical literature.
The objectives of the present study were as follows: 1) to
evaluate whether albumin solution administration improves
the outcomes for NBs in the early postoperative period by
decreasing the occurrence of hyponatremia and 2) to verify
whether the introduction of a semi-elemental diet presents
some advantage over natural diets.
MATERIALS AND METHODS
The data for this study were obtained by reviewing the
records for all NBs with gastroschisis who were treated
between January 2000 and June 2010 at the Neonatal
Intensive Care Unit of the Child Institute of the University
of Sao Paulo School of Medicine. This prospective study
protocol was approved by the institution’s ethical commit-
tee. The study was divided into two phases.
Phase 1 (January 2000 to December 2003): Postoperative
treatment consisted of an infusion of 120 to 150 mL/kg/day
of crystalloid solutions (containing 37.5 mEq Na+/L,
20 mEq K+/L and 9 mEq Ca++/L) followed by 20 mL/kg/
30 min of normal saline, repeated up to three times
whenever the NBs presented with oliguria (defined as
urinary output ,0.8 mL/kg/h) in the first two days of the
postoperative period. Colloid solution (containing normal
saline and 10% albumin) in volumes of 20 mL/kg/30 min
was administered only if there was no increased diuresis.
Enteral nutrition was introduced as soon as the flow of
fluids through the orogastric tube indicated restoration of
intestinal transit. A whole-milk formula appropriate for
each NB’s gestational age was used.
Phase 2 (January 2004 to June 2010): Postoperative
treatment consisted of an infusion of 80 to 100 mL/kg/
day of crystalloid solutions and 20 mL/kg of albumin
solution when oliguria occurred (i.e., diuresis less than
0.8 mL/kg/h). The orogastric tube was removed when
appropriate, and after one or two days without vomiting or
abdominal distension, a semi-elemental diet (PregominH)
was introduced followed by a gradual transition to a full
enteral formula.
In both phases, the aim of the selected surgical treatment
was always primary closure of the defect. A staged
reduction with silo was used only if the total reduction of
visceral contents would impair hemodynamic and respira-
tory function.
The following data were evaluated: gestational age,
weight (at birth and at hospital discharge), APGAR score
(at 1 and 10 minutes), type of gastroschisis (simple or
complicated; associated with atresia, necrosis and/or
intestinal perforation), and type of surgical treatment. We
evaluated whether the NBs received a colloid infusion in the
early postoperative period and the average serum sodium
and albumin levels in the first 72 hours of life. Furthermore,
the occurrence of anasarca and the length of orotracheal
intubation (OTI) were verified.
Because we usually opted for a mild sedation, the
ventilator support method of choice for both groups was
synchronized intermittent mandatory ventilation.
Hyponatremia was defined as sodium serum levels
,135 mEq/L, and hypoalbuminemia was defined as albu-
min serum levels ,3 g/dL. No patient received loop
diuretics during the study period. No severity score was
used.
To examine the nutritional support, we evaluated the
necessary parenteral nutrition (PN) time, time until the
initiation of the enteral diet, and time until reaching the full
enteral diet. We also recorded the occurrence of enteroco-
litis, the length of hospitalization, and mortality.
Initially, we used the Shapiro-Wilk test to investigate the
framing of the numeric variables in the Gaussian model of
distribution. Mann-Whitney’s U test was used to compare
the median values for colloid solution administration with
enteral diet, PN time, length of hospitalization, serum
sodium levels, and serum albumin levels. The chi-squared
test was used to compare the percentages of newborns who
presented anasarca. Simple linear regression tests were used
to analyze the relationship between length of hospitaliza-
tion, gestational age, birth weight, low serum sodium levels,
low serum albumin levels, PN time, and OTI time. A
multiple linear regression model was fitted to assess the
association between each outcome (serum albumin levels,
serum sodium levels, and the need for albumin solution
infusion) and the independent variables. The adjusted
analysis was conducted following a previously formulated
hierarchical model in three levels: 1) gestational age; 2) birth
weight; and 3) hospitalization time, OTI time, time to first
enteral feeding, and time of full enteral feeding. In this
model, the variables were controlled for factors in the same
level and in the superior levels. P-values #0.20 were
adopted in the univariate analysis as necessary to determine
which variables to include in the multiple analyses or when
there was a ß modification of more than 10% for any
variable already in the model. The variables were then
entered using the forward method. The significance level
was set at p,0.05. Moreover, homoscedasticity was assessed
graphically in all regression models. The Stata statistical
software package, Version 10.0 (Stata Corp., College Station,
TX, USA) was used for all statistical calculations.
RESULTS
One hundred thirty-six NBs were included in this study:
36 NBs in the first phase and 100 NBs in the second phase.
The comparisons of perinatal data and surgical treatment
between the two phases are presented in Table 1.
Comparisons and correlations of serum sodium
levels, serum albumin levels, anasarca and the need
for albumin solution infusion
Table 2 shows the data for serum sodium levels, serum
albumin levels, and OTI time in the two study phases and
the results of the statistical comparisons.
Albumin solution administration was necessary in 47.2%
(17/36) and 56.0% (56/100) of NBs in the study’s first and
second phases, respectively (p= 0.47).
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In the first phase, four newborns responded well to
treatment with normal saline boluses, increasing their
urinary output with no need for colloid solution adminis-
tration. Their mean OTI time was 2.5 days, and their mean
natremia level was 123.5 mEq/L.
The percentage of newborns who presented with anasarca
was 19.4% in the first phase and 8% in the second phrase
(p= 0.117).
In all cases, there was no statistical correlation between
serum albumin levels and gestational age, birth weight, and
OTI time or hospitalization time. However, there was a
strong correlation between low serum albumin level and the
time to both the initiation of enteral feeding and a full
enteral diet (p,0.001) (Table 3).
There were no correlations between serum sodium levels
and gestational age, hospitalization time, birth weight, or
time to first and full enteral feedings. There was, however, a
correlation between low serum sodium levels and increased
OTI time (p= 0.04). The need for colloid solution infusion
did not correlate with any of the studied variables (Table 3).
Comparisons regarding nutritional support
The nutritional data, including the fasting time before
beginning the enteral diet, the length of time before the
patient received a full enteral diet, the duration of PN
administration, the length of hospitalization, and weight at
discharge, and the results of the statistical comparisons are
summarized in Table 4.
The time until the first and full enteral feeding, the length
of time for PN and the length of hospitalization were similar
during both phases. However, the discharge weights of the
NBs in the second phase were higher than those of the NBs
in the first phase (p= 0.03). It is important to note that no
patient presented with peripheral edema at the time of
discharge.
Finally, episodes of necrotizing enteritis occurred in two
NBs in the first phase and in none of the NBs in the second
phase (p= 0.11).
The survival rate in Phase 1 was 83.4%; in Phase 2, it was
92% (p= 0.25).
DISCUSSION
This study aimed to clarify the epidemiological, surgical,
and postsurgical data for newborns with gastroschisis.
Initially, we investigated the therapeutic changes related
to extracellular volume expansion and the use of colloid
solutions and their impact on fluid and electrolyte balance
and the final outcomes for NBs with gastroschisis. The NBs
in the two phases of the study (i.e., from 2000 to 2003 and
from 2004 to 2010) had similar gestational ages and birth
weights, which allowed statistical comparisons between the
two groups.
However, although the serum albumin levels were higher
in the patients from Phase 1, the serum sodium levels were
significantly lower in this phase, which may reflect the
excessive use of crystalloid solution infusion during this
phase. Such extreme crystalloid administration was also
ineffective because 47.2% of the NBs in this group remained
oliguric and required albumin solution expansion to
improve diuresis. A similar proportion of patients from
Phase 2 received colloid solution infusion without previous
crystalloid administration.
Table 1 - Gestational age (GA), APGAR scores at 1 and 10
minutes, birth weight (mean¡sd), occurrence of
complicated gastroschisis and silo usage in both phases of
the study.
Variable Phase 1 Phase 2 P-value
GA (weeks) 36 1/7¡2 36 6/7¡1 0.22
APGAR 1 min. 7.8 ¡1.7 7.0¡2.3 0.16
APGAR 10 min. 9.3¡0.7 9.0¡0.7 0.53
Birth weight (g) 2334.8¡478.3 2415.8¡ 463.2 0.30
Silo 16.6% 13.6% 0.97
Complicated
gastroschisis
23.3% 10.0% 0.13
Table 2 - Serum sodium levels, serum albumin levels, and
OTI time in the two phases of the study (mean¡sd).
Variable Phase 1 Phase 2 p-value
Serum sodium
levels (mEq/L)
123.4¡8.6 128.6¡6.4 0.006
Serum albumin
levels (g/dL)
2.5¡0.5 2.0¡0.5 0.02
OTI (days) 4.3¡6.5 5.5¡9.4 0.98
Table 3 - Results of the multiple linear regression analysis
evaluating the association between independent
variables and patient outcomes.
Outcomes p-value*
Serum albumin level
Gestational age (per 1-week increase) 0.382
Birth weight (per 100-g increase) 0.812
OTI time (per 1-day increase) 0.278
Time to the initiation of an enteral diet (per 1-day increase) ,0.001
Time to full enteral diet (per 1-day increase) ,0.001
Hospitalization time (per 1-day increase) 0.382
Serum sodium level
Gestational age (per 1-week increase) 0.533
Birth weight (per 100-g increase) 0.514
OTI time (per 1-day increase) 0.041
Time to the initiation of an enteral diet (per 1-day increase) 0.392
Time to full enteral diet (per 1-day increase) 0.319
Hospitalization time (per 1-day increase) 0.389
Need for colloid infusion
Gestational age (per 1-week increase) 0.312
Birth weight (per 100-g increase) 0.928
OTI time (per 1-day increase) 0.300
Time to the initiation of an enteral diet (per 1-day increase) 0.630
Time to full enteral diet (per 1-day increase) 0.613
Hospitalization time (per 1-day increase) 0.439
*variables with p.0.2 were excluded from the model.
Table 4 - Initiation time for an enteral diet or a full diet,
length of time for parenteral nutrition, weight at
discharge, and hospitalization time in the two phases of
the study (mean¡sd).
Variable Phase 1 Phase 2 p-value
Initiation of an enteral diet
(days)
17.9¡12.8 21.6¡12.9 0.06
Full enteral diet (days) 29.9¡27.1 30.8¡17.2 0.18
PN time (days) 27.3¡28.6 29.2¡17.6 0.06
Weight at discharge (g) 2561.3¡510.7 2814.5¡515.8 0.03
Hospitalization time (days) 35.2¡34.8 34.9¡19.5 0.16
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The joint analysis of the data on serum sodium and
albumin levels from the two time periods did not show any
correlation between these data and the NBs’ initial birth
weights. However, in both phases of the study, low serum
sodium and albumin levels were observed. In experimental
studies of chicken embryos and rabbit fetuses with iatrogenic
gastroschisis, low sodium and chloride serum levels, low
amino acid uptake and glucose deficits were observed along
with the minor expression of a series of genes involved in
enterocyte nutrient absorption (14,15). Finally, Carroll et al.
observed that human fetuses with gastroschisis present with
lower total serum protein levels and higher quantities of
protein in the amniotic fluid, which should reflect protein
losses and intrauterine growth deficits (16).
Thus, after the surgical correction of gastroschisis, the
NBs should present with large exudative losses (e.g., water,
sodium, and proteins) to the so-called ‘‘third space’’ or the
inflamed bowel walls. The low serum albumin levels lead to
decreased coloidosmotic plasma pressure, with fluid leak-
age to the extravascular areas, decreased intravascular
volume, and decreased renal perfusion. In addition, the
increased intra-abdominal pressure from the closed-wall
defect contributes to decreased renal perfusion, which is
responsible for oliguria. Thus, NBs with gastroschisis would
have increased antidiuretic hormone secretion to promote
free water retention and blood-volume reestablishment. The
infusion of crystalloid solutions, however, cannot increase
the blood volume because the infused liquid continues to
leak into the interstitial space due to the previous low
albumin levels; as a result, the serum sodium concentration
remains low. Consequently, edema in the pulmonary
interstice occurs, with defects in gaseous exchange and
ventilatory mechanics. This effect explains the correlation
between low serum levels and increased OTI time because
both of these values are probably related to the excessive
infusion of crystalloid solutions (p= 0.04). Furthermore,
newborns in the first phase received sodium at levels much
higher than normal maintenance, which increased their
tendency to present with anasarca. Finally, despite the
therapeutic administration of albumin solutions in the
second phase of the study, the serum albumin levels
decreased (p= 0.02), although the serum sodium levels
may have increased (p=0.006). The albumin levels may
have initially decreased when albumin was administered,
probably because the intravascular space had been
expanded. The Phase 2 patients did indeed have a tendency
to be less edematous than the newborns in Phase 1, which
explains why the low sodium levels in the second phase did
not correlate with longer OTI times.
The low serum albumin levels did not correlate with
longer OTI times, although a correlation with the time to
first and full enteral feeding was observed. Additionally, the
need for albumin solution expansion did not correlate with
any of the studied variables. These facts suggest that the low
albumin levels combined with hemodynamic alterations
and oliguria (requiring the administration of exogenous
albumin), which are significant morbidity factors, did not
influence the time of postoperative ileus. In fact, the
mechanisms of the intestinal dysfunction observed in
gastroschisis patients are not fully known. Intestinal
dysfunction can be explained by changes and immaturity
of the enteric nervous plexus and by exposure of the
intestine to the amniotic fluid, as described in experimental
investigations in rabbits (12, 17).
The results of the present study agree with several studies
of adult patients undergoing abdominal surgery or after
trauma. These studies found that maintaining albumin
concentrations above 3.5 g/dL with exogenous albumin did
not alter the length of postoperative ileus or hospital stay and
did not improve pulmonary function or final mortality (18).
There are few studies of albumin treatment in pediatric
surgical patients. In an interesting study by Kenny et al. (19),
hypoalbuminemia occurred in 27% of postoperative neo-
nates, and the mortality of the hypoalbuminemic infants was
greater but was unrelated to the albumin level or albumin
treatment. Finally, two randomized controlled studies
comparing isotonic saline to 5% albumin in hypotensive
term and preterm neonates showed that these two solutions
are equally effective in treating hypotension and that patients
treated with albumin had greater fluid retention (20,21). It is
possible that the increased fluid retention was responsible for
the decreased serum albumin levels observed in our Phase 2
patients. Another explanation would be the extravasation of
albumin into the interstitial space.
Another interesting difference between the two study
periods is the higher body weights found in the second
phase, even though no weight differences were observed
between the two phases at the beginning of the enteral diet.
Moreover, there was a tendency toward more episodes of
necrotizing enterocolitis in the first group than in the second
group. Such data suggest a possible benefit of initially
introducing a semi-elemental diet and then gradually
transitioning to integral formulas. This result agrees with a
previous report suggesting that the early introduction of
minimal enteral feeding and the controlled increase of
nutritional elements after bowel reintegration significantly
improves the NBs’ outcomes after the surgical repair of
gastroschisis (13).
The comparisons regarding nutritional support demon-
strated that no differences occurred between the two phases
of the study, even though the albumin solution administra-
tion in the second phase of the study may have exacerbated
the low serum sodium levels and decreased the serum
albumin levels (Table 2). In both phases of the study, the
time to initiation of the enteral diet, time to reach the full
enteral diet, time on PN, and length of hospitalization did
not vary. These results are in accord with the conclusion of a
previous study of 163 gastroschisis patients that demon-
strated that hyponatremia and hypoalbuminemia could not
have influenced intestinal function because these alterations
were not correlated with the number of days on PN (10).
In conclusion, the present study suggests that the
administration of albumin solution to NBs in the early
postoperative period of gastroschisis repair improved the
decreased serum sodium levels but did not improve the
final outcomes. In addition, the introduction of a semi-
elemental diet was responsible for increased body weight at
hospital discharge.
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